These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 30599479)
1. Early-life exposure to endocrine disrupting chemicals associates with childhood obesity. Yang C; Lee HK; Kong APS; Lim LL; Cai Z; Chung ACK Ann Pediatr Endocrinol Metab; 2018 Dec; 23(4):182-195. PubMed ID: 30599479 [TBL] [Abstract][Full Text] [Related]
2. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Wan MLY; Co VA; El-Nezami H Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127 [TBL] [Abstract][Full Text] [Related]
3. Association between pre- and postnatal exposure to endocrine-disrupting chemicals and birth and neurodevelopmental outcomes: an extensive review. Yesildemir O; Celik MN Clin Exp Pediatr; 2024 Jul; 67(7):328-346. PubMed ID: 37986566 [TBL] [Abstract][Full Text] [Related]
4. Childhood obesity and endocrine disrupting chemicals. Kim JT; Lee HK Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):219-225. PubMed ID: 29301181 [TBL] [Abstract][Full Text] [Related]
5. Urinary levels of endocrine-disrupting chemicals, including bisphenols, bisphenol A diglycidyl ethers, benzophenones, parabens, and triclosan in obese and non-obese Indian children. Xue J; Wu Q; Sakthivel S; Pavithran PV; Vasukutty JR; Kannan K Environ Res; 2015 Feb; 137():120-8. PubMed ID: 25531816 [TBL] [Abstract][Full Text] [Related]
6. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Braun JM Nat Rev Endocrinol; 2017 Mar; 13(3):161-173. PubMed ID: 27857130 [TBL] [Abstract][Full Text] [Related]
7. Impact of endocrine-disrupting chemicals on thyroid function and brain development. Ibhazehiebo K; Koibuchi N Expert Rev Endocrinol Metab; 2014 Nov; 9(6):579-591. PubMed ID: 30736196 [TBL] [Abstract][Full Text] [Related]
8. Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental evidence. Ding T; Yan W; Zhou T; Shen W; Wang T; Li M; Zhou S; Wu M; Dai J; Huang K; Zhang J; Chang J; Wang S Environ Pollut; 2022 Jul; 305():119269. PubMed ID: 35405219 [TBL] [Abstract][Full Text] [Related]
9. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review. Sirohi D; Al Ramadhani R; Knibbs LD Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210 [TBL] [Abstract][Full Text] [Related]
10. Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study. Fabbri L; Garlantézec R; Audouze K; Bustamante M; Carracedo Á; Chatzi L; Ramón González J; Gražulevičienė R; Keun H; Lau CE; Sabidó E; Siskos AP; Slama R; Thomsen C; Wright J; Lun Yuan W; Casas M; Vrijheid M; Maitre L Environ Int; 2023 Mar; 173():107856. PubMed ID: 36867994 [TBL] [Abstract][Full Text] [Related]
11. The impact of endocrine-disrupting chemical exposure in the mammalian hypothalamic-pituitary axis. Graceli JB; Dettogni RS; Merlo E; Niño O; da Costa CS; Zanol JF; Ríos Morris EA; Miranda-Alves L; Denicol AC Mol Cell Endocrinol; 2020 Dec; 518():110997. PubMed ID: 32841708 [TBL] [Abstract][Full Text] [Related]
12. Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders. Kajta M; Wójtowicz AK Pharmacol Rep; 2013; 65(6):1632-9. PubMed ID: 24553011 [TBL] [Abstract][Full Text] [Related]
13. Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis. Ribeiro CM; Beserra BTS; Silva NG; Lima CL; Rocha PRS; Coelho MS; Neves FAR; Amato AA BMJ Open; 2020 Jun; 10(6):e033509. PubMed ID: 32565448 [TBL] [Abstract][Full Text] [Related]
17. Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children. Midya V; Colicino E; Conti DV; Berhane K; Garcia E; Stratakis N; Andrusaityte S; Basagaña X; Casas M; Fossati S; Gražuleviciene R; Haug LS; Heude B; Maitre L; McEachan R; Papadopoulou E; Roumeliotaki T; Philippat C; Thomsen C; Urquiza J; Vafeiadi M; Varo N; Vos MB; Wright J; McConnell R; Vrijheid M; Chatzi L; Valvi D JAMA Netw Open; 2022 Jul; 5(7):e2220176. PubMed ID: 35793087 [TBL] [Abstract][Full Text] [Related]
18. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons. Lee DH; Jacobs DR J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909 [TBL] [Abstract][Full Text] [Related]
19. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Chen Y; Wang Y; Cui Z; Liu W; Liu B; Zeng Q; Zhao X; Dou J; Cao J Front Public Health; 2023; 11():1154837. PubMed ID: 37033031 [TBL] [Abstract][Full Text] [Related]
20. Endocrine-Disrupting Chemicals and Disease Endpoints. Ahn C; Jeung EB Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]